Evidence map›Paper›PMID 24308383›Full record

ArticleJournal of the American Chemical Society2014

A concise synthesis of (-)-lasonolide A.

Barry M Trost, Craig E Stivala, Kami L Hull, Audris Huang, Daniel R Fandrick

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Total Synthesis of (-)-Lasonolide A.Journal of the American Chemical Society · 2016
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Barry M TrostDepartment of Chemistry, Stanford University , Stanford, California 94305-5580, United States.
Craig E Stivala
Kami L Hull
Audris Huang
Daniel R Fandrick

Funding

NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDSR01GM033049 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI TROST, BARRY M · 1985 to 2016
$6.5M
Total Synthesis of Calyciphylline A - A Potent Cytotoxic AlkaloidF32GM101747 · NIGMS · STANFORD UNIVERSITY · PI STIVALA, CRAIG EVAN · 2012 to 2014
$150k
The Total Synthesis of (-)-Fijianolide DF32GM086093 · NIGMS · STANFORD UNIVERSITY · PI HULL, KAMI LEE · 2009 to 2011
$144k
A Novel Sterodivergent Approach to Amphidinolide NF32GM077840 · NIGMS · STANFORD UNIVERSITY · PI HUANG, AUDRIS · 2006 to 2009
$97k
NIGMS NIH HHS F32 GM077840NIGMS NIH HHS F32 GM086093NIGMS NIH HHS F32 GM101747NIGMS NIH HHS GM077840NIGMS NIH HHS GM086093NIGMS NIH HHS GM101747NIGMS NIH HHS GM33049NIGMS NIH HHS R01 GM033049
6 · The paper itself

Abstract

Lasonolide A is a novel polyketide displaying potent anticancer activity across a broad range of cancer cell lines. Here, an enantioselective convergent total synthesis of the (-)-lasonolide A in 16 longest linear and 34 total steps is described. This approach significantly reduces the step count compared to other known syntheses. The synthetic strategy utilizes alkyne-bearing substrates as core building blocks and is highlighted by stitching together two similarly complex halves via a key Ru-catalyzed alkene-alkyne coupling and macrolactionization.

Indexed as

Chemistry Techniques, SyntheticAntineoplastic AgentsCatalysisMacrolidesMolecular StructureRutheniumStereoisomerismAntineoplastic Agentslasonolide AMacrolidesRuthenium

Identifiers

PMID24308383
PMCPMC3939832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.